Review of treatment options for oligometastatic non-small cell lung cancer.

Review of treatment options for oligometastatic non-small cell lung cancer. Clin Adv Hematol Oncol. 2015 Mar;13(3):186-93 Authors: Folkert MR, Timmerman R Abstract Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non-small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or "oligometastatic" disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research. PMID: 26352427 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research